Revenues (Tables)

6 Months Ended

Jun. 30, 2022

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue by Product and Geographic Area

Revenues by product line. The following table represents total net revenues by product line:

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
COVID-19 (1)	$	43,378	$	12,070	$	74,411	$	40,215
Genomics (1)		15,486		19,498		30,578		30,316
HIV		10,357		10,944		18,523		19,722
HCV		3,691		4,300		6,948		6,668
Substance abuse		2,630		2,629		5,191		4,591
Microbiome (1)		1,832		2,447		3,822		4,198
Laboratory services		1,204		3,114		2,938		5,611
Other product and service revenues		589		739		1,992		999
Net product and services revenues		79,167		55,741		144,403		112,320
Royalty income		642		875		1,326		2,136
Other non-product revenues		422		991		2,209		1,733
Other revenues		1,064		1,866		3,535		3,869
Net revenues	$	80,231	$	57,607	$	147,938	$	116,189

(1) 2021 COVID-19, Genomics and Microbiome revenues were reclassified to reflect the correct classification of the product line sales. The reclassification increased (decreased) the product line revenues for the three months ended June 30, 2021 by $490, $(84) and $(406), respectively. The reclassification increased (decreased) the product line revenues for the six months ended June 30, 2021 by $1,073, $(330) and $(743), respectively.

Revenues by geographic area. The following table represents total net revenues by geographic area, based on the location of the customer:

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
United States	$	70,320	$	47,601	$	128,307	$	96,700
Europe		2,436		3,325		6,722		7,877
Other regions		7,475		6,681		12,909		11,612
	$	80,231	$	57,607	$	147,938	$	116,189